Inhibitory effects of methyl brevifolincarboxylate isolated from Phyllanthus niruri L. on platelet aggregation

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 2, 2007, Pages 382-384

  Iizuka, Toru ^a   Nagai, Masahiro ^a   Taniguchi, Akemi ^b   Moriyama, Hiroyoshi ^b   Hoshi, Keiko ^b  

^a HOSHI UNIVERSITY   (Japan)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Inhibitory effect; Methyl brevifolincarboxylate; Phyllanthus niruri; Platelet aggregation

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; COLLAGEN; METHANOL; METHYLBREVIFOLINCARBOXYLATE; PHYLLANTHUS NIRURI EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; INHIBITION KINETICS; MASS SPECTROMETRY; PHYLLANTHUS; PLANT LEAF; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

BENZOPYRANS; BLOOD PLATELETS; HUMANS; PHYLLANTHUS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

EID: 33846988258     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.382     Document Type: Article

References (20)

1. Moriyama H., Iizuka T., Nagai N., Terazono M., Hoshi K., Nat. Med., 56, 178-183 (2002).
2. Moriyama H., Iizuka T., Nagai, Hoshi K., Biol. Pharm. Bull., 26, 1361-1364 (2003).
3. Ozaki Y., Satoh K., Yatomi Y., Yamamoto T., Shirasawa Y., Kume S., Anal. Biochem., 218, 284-294 (1994).
4. Calixto J. B., Santos A. R. S., Cechinel Filho V., Yunes R. A., Med. Res. Rev., 18, 225-258 (1998).
5. Subeki S., Matsuura H., Takahashi K., Yamasaki M., Yamato O., Maede Y., Katakura K., Kobayashi S., Trimurningsih T., Chairul C., Yoshihara T., J. Nat. Prod., 68, 537-539 (2005).
6. Tona L., Ngimbi N. P., Tsakala M., Mesia K., Cimanga K., Apers S., De Bruyne T., Pieters L., Totte J., Vlietinck A. J., J. Ethnopharmacol., 68, 193-203 (1999).
7. Campos A. H., Schor N., Nephron, 81, 393-397 (1999).
8. Santos A. R., Filho V. C., Niero R., Viana A. M., Moreno F. N., Campos M. M., Yunes R. A., Calixto J. B., J. Pharm. Pharmacol., 46, 755-759 (1994).
9. Huang R. L., Huang Y. L., Ou J. C., Chen C. C., Hsu F. L., Chang C., Phytother. Res., 17, 449-453 (2003).
10. Ueno H., Horie S., Nishi Y., Shogawa H., Kawasaki M., Suzuki S., Hayashi T., Arisawa M., Shimizu M., Yoshizaki M., Morita N., J. Nat. Prod., 51, 357-359 (1988).
11. Elfahmi, Batterman S., Koulman A., Hackl T., Bos R., Kayser O., Woerdenbag H. J., Quax W. J., J. Nat. Prod., 69, 55-58 (2006).
12. Mellinger C. G., Carbonero E. R., Cipriani T. R., Gorin P. A., Iacomini M., J. Nat. Prod., 68, 129-132 (2005).
13. Joshi B. S., Gawad D. H., Pelletier S. W., Kartha G., Bhandary K., J. Nat. Prod., 49, 614-620 (1986).
14. Chauhan J. S., Sultan M., Srivastava S. K., Planta Med., 32, 217-222 (1977).
15. Yao Q.-Q., Zuo C.-X., Acta Pharm. Sin., 28, 829-835 (1993).
16. http://chiryo.phar.nagoya-cu.ac.jp/javstat/Bonferro-j.htm.
17. Iizuka T., Moriyama H., Nagai M., Biol. Pharm. Bull., 29, 177-180 (2006).
18. Kutsuna H., Fujii S., Kitamura K., Komatsu K., Nakano M., Yakugaku Zasshi, 108, 1101-1103 (1988).
19. Chang F.-R., Wei J.-L., Teng C.-M., Wu Y.-C., J. Nat. Prod., 61, 1457-1461 (1998).
20. Hourani S. M. O., Drug Dev. Res., 52, 140-149 (2001).